Page last updated: 2024-11-06

mitomycin and Neuroendocrine Tumors

mitomycin has been researched along with Neuroendocrine Tumors in 4 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research Excerpts

ExcerptRelevanceReference
"Measurement of serum pancreastatin levels is an easy and useful method to predict success in patients who undergo HACE plus somatostatin therapy for metastatic neuroendocrine tumors to the liver."7.71Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. ( Desai, DC; Jung, SS; Khabiri, H; Martin, EW; O'Dorisio, TM; Schirmer, WJ; Villanueva, V, 2001)
"The objective of our study was to retrospectively determine the effectiveness of hepatic transarterial chemotherapy using two therapeutic protocols-mitomycin C alone and combined mitomycin C and gemcitabine-on local tumor control and survival rate in patients with liver metastases from neuroendocrine tumors."3.75Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols. ( Gruber, T; Hammerstingl, R; Naguib, NN; Nour-Eldin, NE; Vogl, TJ, 2009)
"Measurement of serum pancreastatin levels is an easy and useful method to predict success in patients who undergo HACE plus somatostatin therapy for metastatic neuroendocrine tumors to the liver."3.71Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. ( Desai, DC; Jung, SS; Khabiri, H; Martin, EW; O'Dorisio, TM; Schirmer, WJ; Villanueva, V, 2001)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Barrak, D1
Desale, S1
Yoon, JJ1
Dugan, MM1
Kodavanti, PP1
Sampah, ME1
Sugarbaker, PH1
Sabourin, JC1
Vogl, TJ1
Gruber, T1
Naguib, NN1
Hammerstingl, R1
Nour-Eldin, NE1
Desai, DC1
O'Dorisio, TM1
Schirmer, WJ1
Jung, SS1
Khabiri, H1
Villanueva, V1
Martin, EW1

Reviews

2 reviews available for mitomycin and Neuroendocrine Tumors

ArticleYear
Appendiceal tumors with glandular and neuroendocrine features exhibiting peritoneal metastases - Critical evaluation of outcome following cytoreductive surgery with perioperative chemotherapy.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2021, Volume: 47, Issue:6

    Topics: Adenocarcinoma; Administration, Intravenous; Adult; Aged; Antineoplastic Combined Chemotherapy Proto

2021
[Peritoneal tumor pathology: case n(o) 2: a "sticky" peritoneal tumor].
    Annales de pathologie, 2015, Volume: 35, Issue:4

    Topics: Abdominal Pain; Adult; Antineoplastic Agents, Alkylating; Appendectomy; Appendiceal Neoplasms; Combi

2015

Other Studies

2 other studies available for mitomycin and Neuroendocrine Tumors

ArticleYear
Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols.
    AJR. American journal of roentgenology, 2009, Volume: 193, Issue:4

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined C

2009
Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors.
    Regulatory peptides, 2001, Jan-12, Volume: 96, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Chemoembolization, Therape

2001